Search research articles
Contact Us
Filters
Showing results (691-700 of 762) with videos related to
Page
of 77
Sort By:
The American Journal of Cardiology
|
November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk
J Shepherd, G J Blauw, M B Murphy, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Beatriz German, Katherine L Morel, Teia Noel, et al.
BJU International
|
August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer
David R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
The Journal of Clinical Investigation
|
June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
The Journal of Clinical Investigation
|
March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer
Larissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.
Circulation
|
November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Chris J Packard, Ian Ford, Michele Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk
P J Houx, J Shepherd, G-J Blauw, et al.
Science Advances
|
September 16, 2020
The fungal collaboration gradient dominates the root economics space in plants
Joana Bergmann, Alexandra Weigelt, Fons van der Plas, et al.
Cancers
|
January 11, 2024
Intragenic <i>EGFR::EGFR</i>.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors
Lan Zheng, Rajyalakshmi Luthra, Hector A Alvarez, et al.
Nature Medicine
|
April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
Paloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Page
of 77
Search research articles
Search
Showing results (691-700 of 762) with videos related to
Sort By:
Page
of 77
The American Journal of Cardiology
|
November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk
J Shepherd, G J Blauw, M B Murphy, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer
Beatriz German, Katherine L Morel, Teia Noel, et al.
BJU International
|
August 16, 2014
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer
David R Ziehr, Ming-Hui Chen, Danjie Zhang, et al.
The Journal of Clinical Investigation
|
June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D
Kazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
The Journal of Clinical Investigation
|
March 31, 2026
Proliferation associates with greater sensitivity to androgen receptor pathway inhibition for metastatic prostate cancer
Larissa Mendes, Peter F Dutey-Magni, Emily Grist, et al.
Circulation
|
November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Chris J Packard, Ian Ford, Michele Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk
P J Houx, J Shepherd, G-J Blauw, et al.
Science Advances
|
September 16, 2020
The fungal collaboration gradient dominates the root economics space in plants
Joana Bergmann, Alexandra Weigelt, Fons van der Plas, et al.
Cancers
|
January 11, 2024
Intragenic <i>EGFR::EGFR</i>.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors
Lan Zheng, Rajyalakshmi Luthra, Hector A Alvarez, et al.
Nature Medicine
|
April 26, 2016
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
Paloma Cejas, Lewyn Li, Nicholas K O'Neill, et al.
Page
of 77